A proven roadmap for innovation and commercialization

We empower inventors — paving pathways, clearing obstacles and dedicating significant resources to technology transfer.

Impact Dashboard

251

FY22 Invention Disclosures

79

FY22 U.S. Patents Issued

$14.6M

FY22 Licensing Revenue

7

FY22 New IP Based Startups

This is WashU Innovation

The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.

Explore our innovation community

Needlemans commit $15 million to boost drug discovery

A generous gift from longtime benefactors of Washington University School of Medicine in St. Louis establishes the Needleman Program for Innovation and Commercialization. For a select number of projects, the new program will provide funding to help move promising therapeutics towards the stage where the Food and Drug Administration grants investigational new drug (IND) status. The program is now accepting proposals through March 15th (guidelines below).

Awardees announced for Needleman innovation, commercialization program

January 12, 2024

The university’s recently established Needleman Program for Innovation and Commercialization (NPIC) will provide critical funding to help move research toward early-stage clinical trials and commercialization. The first three awardees are Carl DeSelm, MD, PhD, John F. DiPersio, MD, PhD, and Kory Lavine, MD, PhD. 

University launches new era of progress in neuroscience

December 13, 2023

Understanding the brain and nervous system is one of the most pressing challenges in medicine. To meet this challenge, WashU Medicine has built and is opening the Neuroscience Research Building, a 609,000-square-foot facility expected to be among the nation’s premier neuroscience research hubs.


Announcements

Resources for Students & Alumni

The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.